Outside of EBV, a similar mechanism was reported in PARP1-deficient chronic myelogenous leukemia cells, which showed reduced HIF-1 transcriptional activation dependent on PARP1 enzymatic activity. Here, SETD2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.